 | • レポートコード：MRC2-11QY12415 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は乳管内乳頭腫治療のグローバル市場について調査・分析したレポートです。種類別（マイクロドケクトミー、全管切除、投薬、その他）市場規模、用途別（病院、クリニック、学術・研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別乳管内乳頭腫治療の競争状況、市場シェア ・世界の乳管内乳頭腫治療市場：種類別市場規模 2015年-2020年（マイクロドケクトミー、全管切除、投薬、その他） ・世界の乳管内乳頭腫治療市場：種類別市場規模予測 2021年-2026年（マイクロドケクトミー、全管切除、投薬、その他） ・世界の乳管内乳頭腫治療市場：用途別市場規模 2015年-2020年（病院、クリニック、学術・研究機関、その他） ・世界の乳管内乳頭腫治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、学術・研究機関、その他） ・北米の乳管内乳頭腫治療市場分析：米国、カナダ ・ヨーロッパの乳管内乳頭腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの乳管内乳頭腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の乳管内乳頭腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの乳管内乳頭腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Boston Scientific、Medtronic、Cook Medical、Allergen、Olympus、Teva Pharmaceutical、Mylan Pharmaceuticals、Entax Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
An intraductal papilloma is a benign, or noncancerous, breast tumour that forms in a milk duct and is made of gland and fibrous tissue as well as blood vessels. These generally appear as lumps after breast examination and may cause nipple discharge or bleeding. Intraductal papilloma most commonly occur in women between ages 35 and 55. Central/solitary papillomas are generally benign while multiple papillomas, have been associated with a slightly higher risk of breast cancer.
The Americas account for a significant market share owing to extensive volume of surgeries performed and high expenditure on the health care. Additionally, the fastest uptake of new products and surgical procedures in the US drive the intraductal papilloma market.
Market Analysis and Insights: Global Intraductal Papilloma Treatment Market
The global Intraductal Papilloma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Intraductal Papilloma Treatment Scope and Market Size
Intraductal Papilloma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intraductal Papilloma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Boston Scientific
Medtronic
Cook Medical
Allergen
Olympus
Teva Pharmaceutical
Mylan Pharmaceuticals
Entax Medical
Market segment by Type, the product can be split into
Microdochectomy
Total Duct Excision
Medication
Others
Market segment by Application, split into
Hospitals
Clinics
Academic and Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intraductal Papilloma Treatment Revenue
1.4 Market by Type
1.4.1 Global Intraductal Papilloma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Microdochectomy
1.4.3 Total Duct Excision
1.4.4 Medication
1.4.5 Others
1.5 Market by Application
1.5.1 Global Intraductal Papilloma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Academic and Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Intraductal Papilloma Treatment Market Perspective (2015-2026)
2.2 Global Intraductal Papilloma Treatment Growth Trends by Regions
2.2.1 Intraductal Papilloma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Intraductal Papilloma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Intraductal Papilloma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Intraductal Papilloma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Intraductal Papilloma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Intraductal Papilloma Treatment Players by Market Size
3.1.1 Global Top Intraductal Papilloma Treatment Players by Revenue (2015-2020)
3.1.2 Global Intraductal Papilloma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Intraductal Papilloma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Intraductal Papilloma Treatment Market Concentration Ratio
3.2.1 Global Intraductal Papilloma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Intraductal Papilloma Treatment Revenue in 2019
3.3 Intraductal Papilloma Treatment Key Players Head office and Area Served
3.4 Key Players Intraductal Papilloma Treatment Product Solution and Service
3.5 Date of Enter into Intraductal Papilloma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Intraductal Papilloma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Intraductal Papilloma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Intraductal Papilloma Treatment Market Size by Application (2015-2020)
5.2 Global Intraductal Papilloma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Intraductal Papilloma Treatment Market Size (2015-2020)
6.2 Intraductal Papilloma Treatment Key Players in North America (2019-2020)
6.3 North America Intraductal Papilloma Treatment Market Size by Type (2015-2020)
6.4 North America Intraductal Papilloma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Intraductal Papilloma Treatment Market Size (2015-2020)
7.2 Intraductal Papilloma Treatment Key Players in Europe (2019-2020)
7.3 Europe Intraductal Papilloma Treatment Market Size by Type (2015-2020)
7.4 Europe Intraductal Papilloma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Intraductal Papilloma Treatment Market Size (2015-2020)
8.2 Intraductal Papilloma Treatment Key Players in China (2019-2020)
8.3 China Intraductal Papilloma Treatment Market Size by Type (2015-2020)
8.4 China Intraductal Papilloma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Intraductal Papilloma Treatment Market Size (2015-2020)
9.2 Intraductal Papilloma Treatment Key Players in Japan (2019-2020)
9.3 Japan Intraductal Papilloma Treatment Market Size by Type (2015-2020)
9.4 Japan Intraductal Papilloma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Intraductal Papilloma Treatment Market Size (2015-2020)
10.2 Intraductal Papilloma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Intraductal Papilloma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Intraductal Papilloma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Intraductal Papilloma Treatment Market Size (2015-2020)
11.2 Intraductal Papilloma Treatment Key Players in India (2019-2020)
11.3 India Intraductal Papilloma Treatment Market Size by Type (2015-2020)
11.4 India Intraductal Papilloma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Intraductal Papilloma Treatment Market Size (2015-2020)
12.2 Intraductal Papilloma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Intraductal Papilloma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Intraductal Papilloma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Boston Scientific
13.1.1 Boston Scientific Company Details
13.1.2 Boston Scientific Business Overview
13.1.3 Boston Scientific Intraductal Papilloma Treatment Introduction
13.1.4 Boston Scientific Revenue in Intraductal Papilloma Treatment Business (2015-2020))
13.1.5 Boston Scientific Recent Development
13.2 Medtronic
13.2.1 Medtronic Company Details
13.2.2 Medtronic Business Overview
13.2.3 Medtronic Intraductal Papilloma Treatment Introduction
13.2.4 Medtronic Revenue in Intraductal Papilloma Treatment Business (2015-2020)
13.2.5 Medtronic Recent Development
13.3 Cook Medical
13.3.1 Cook Medical Company Details
13.3.2 Cook Medical Business Overview
13.3.3 Cook Medical Intraductal Papilloma Treatment Introduction
13.3.4 Cook Medical Revenue in Intraductal Papilloma Treatment Business (2015-2020)
13.3.5 Cook Medical Recent Development
13.4 Allergen
13.4.1 Allergen Company Details
13.4.2 Allergen Business Overview
13.4.3 Allergen Intraductal Papilloma Treatment Introduction
13.4.4 Allergen Revenue in Intraductal Papilloma Treatment Business (2015-2020)
13.4.5 Allergen Recent Development
13.5 Olympus
13.5.1 Olympus Company Details
13.5.2 Olympus Business Overview
13.5.3 Olympus Intraductal Papilloma Treatment Introduction
13.5.4 Olympus Revenue in Intraductal Papilloma Treatment Business (2015-2020)
13.5.5 Olympus Recent Development
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Details
13.6.2 Teva Pharmaceutical Business Overview
13.6.3 Teva Pharmaceutical Intraductal Papilloma Treatment Introduction
13.6.4 Teva Pharmaceutical Revenue in Intraductal Papilloma Treatment Business (2015-2020)
13.6.5 Teva Pharmaceutical Recent Development
13.7 Mylan Pharmaceuticals
13.7.1 Mylan Pharmaceuticals Company Details
13.7.2 Mylan Pharmaceuticals Business Overview
13.7.3 Mylan Pharmaceuticals Intraductal Papilloma Treatment Introduction
13.7.4 Mylan Pharmaceuticals Revenue in Intraductal Papilloma Treatment Business (2015-2020)
13.7.5 Mylan Pharmaceuticals Recent Development
13.8 Entax Medical
13.8.1 Entax Medical Company Details
13.8.2 Entax Medical Business Overview
13.8.3 Entax Medical Intraductal Papilloma Treatment Introduction
13.8.4 Entax Medical Revenue in Intraductal Papilloma Treatment Business (2015-2020)
13.8.5 Entax Medical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Intraductal Papilloma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Intraductal Papilloma Treatment Revenue
Table 3. Ranking of Global Top Intraductal Papilloma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Intraductal Papilloma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Microdochectomy
Table 6. Key Players of Total Duct Excision
Table 7. Key Players of Medication
Table 8. Key Players of Others
Table 9. Global Intraductal Papilloma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Intraductal Papilloma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Intraductal Papilloma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Intraductal Papilloma Treatment Market Share by Regions (2015-2020)
Table 13. Global Intraductal Papilloma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Intraductal Papilloma Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Intraductal Papilloma Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Intraductal Papilloma Treatment Players
Table 20. Global Intraductal Papilloma Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Intraductal Papilloma Treatment Market Share by Players (2015-2020)
Table 22. Global Top Intraductal Papilloma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intraductal Papilloma Treatment as of 2019)
Table 23. Global Intraductal Papilloma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Intraductal Papilloma Treatment Product Solution and Service
Table 26. Date of Enter into Intraductal Papilloma Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Intraductal Papilloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Intraductal Papilloma Treatment Market Size Share by Type (2015-2020)
Table 30. Global Intraductal Papilloma Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Intraductal Papilloma Treatment Market Size Share by Application (2015-2020)
Table 32. Global Intraductal Papilloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Intraductal Papilloma Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Intraductal Papilloma Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Intraductal Papilloma Treatment Market Share (2019-2020)
Table 36. North America Intraductal Papilloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Intraductal Papilloma Treatment Market Share by Type (2015-2020)
Table 38. North America Intraductal Papilloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Intraductal Papilloma Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Intraductal Papilloma Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Intraductal Papilloma Treatment Market Share (2019-2020)
Table 42. Europe Intraductal Papilloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Intraductal Papilloma Treatment Market Share by Type (2015-2020)
Table 44. Europe Intraductal Papilloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Intraductal Papilloma Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Intraductal Papilloma Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Intraductal Papilloma Treatment Market Share (2019-2020)
Table 48. China Intraductal Papilloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Intraductal Papilloma Treatment Market Share by Type (2015-2020)
Table 50. China Intraductal Papilloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Intraductal Papilloma Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Intraductal Papilloma Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Intraductal Papilloma Treatment Market Share (2019-2020)
Table 54. Japan Intraductal Papilloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Intraductal Papilloma Treatment Market Share by Type (2015-2020)
Table 56. Japan Intraductal Papilloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Intraductal Papilloma Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Intraductal Papilloma Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Intraductal Papilloma Treatment Market Share (2019-2020)
Table 60. Southeast Asia Intraductal Papilloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Intraductal Papilloma Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Intraductal Papilloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Intraductal Papilloma Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Intraductal Papilloma Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Intraductal Papilloma Treatment Market Share (2019-2020)
Table 66. India Intraductal Papilloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Intraductal Papilloma Treatment Market Share by Type (2015-2020)
Table 68. India Intraductal Papilloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Intraductal Papilloma Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Intraductal Papilloma Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Intraductal Papilloma Treatment Market Share (2019-2020)
Table 72. Central & South America Intraductal Papilloma Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Intraductal Papilloma Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Intraductal Papilloma Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Intraductal Papilloma Treatment Market Share by Application (2015-2020)
Table 76. Boston Scientific Company Details
Table 77. Boston Scientific Business Overview
Table 78. Boston Scientific Product
Table 79. Boston Scientific Revenue in Intraductal Papilloma Treatment Business (2015-2020) (Million US$)
Table 80. Boston Scientific Recent Development
Table 81. Medtronic Company Details
Table 82. Medtronic Business Overview
Table 83. Medtronic Product
Table 84. Medtronic Revenue in Intraductal Papilloma Treatment Business (2015-2020) (Million US$)
Table 85. Medtronic Recent Development
Table 86. Cook Medical Company Details
Table 87. Cook Medical Business Overview
Table 88. Cook Medical Product
Table 89. Cook Medical Revenue in Intraductal Papilloma Treatment Business (2015-2020) (Million US$)
Table 90. Cook Medical Recent Development
Table 91. Allergen Company Details
Table 92. Allergen Business Overview
Table 93. Allergen Product
Table 94. Allergen Revenue in Intraductal Papilloma Treatment Business (2015-2020) (Million US$)
Table 95. Allergen Recent Development
Table 96. Olympus Company Details
Table 97. Olympus Business Overview
Table 98. Olympus Product
Table 99. Olympus Revenue in Intraductal Papilloma Treatment Business (2015-2020) (Million US$)
Table 100. Olympus Recent Development
Table 101. Teva Pharmaceutical Company Details
Table 102. Teva Pharmaceutical Business Overview
Table 103. Teva Pharmaceutical Product
Table 104. Teva Pharmaceutical Revenue in Intraductal Papilloma Treatment Business (2015-2020) (Million US$)
Table 105. Teva Pharmaceutical Recent Development
Table 106. Mylan Pharmaceuticals Company Details
Table 107. Mylan Pharmaceuticals Business Overview
Table 108. Mylan Pharmaceuticals Product
Table 109. Mylan Pharmaceuticals Revenue in Intraductal Papilloma Treatment Business (2015-2020) (Million US$)
Table 110. Mylan Pharmaceuticals Recent Development
Table 111. Entax Medical Business Overview
Table 112. Entax Medical Product
Table 113. Entax Medical Company Details
Table 114. Entax Medical Revenue in Intraductal Papilloma Treatment Business (2015-2020) (Million US$)
Table 115. Entax Medical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intraductal Papilloma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Microdochectomy Features
Figure 3. Total Duct Excision Features
Figure 4. Medication Features
Figure 5. Others Features
Figure 6. Global Intraductal Papilloma Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Academic and Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Intraductal Papilloma Treatment Report Years Considered
Figure 12. Global Intraductal Papilloma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Intraductal Papilloma Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Intraductal Papilloma Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Intraductal Papilloma Treatment Market Share by Players in 2019
Figure 17. Global Top Intraductal Papilloma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intraductal Papilloma Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Intraductal Papilloma Treatment Revenue in 2019
Figure 19. North America Intraductal Papilloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Intraductal Papilloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Intraductal Papilloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Intraductal Papilloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Intraductal Papilloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Intraductal Papilloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Intraductal Papilloma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
乳管内乳頭腫の世界市場（～2026年） An intraductal papilloma is a benign, or noncancerous, breast tumour that forms in a milk duct and is made of gland and fibrous tissue as well as blood vessels. These generally appear as lumps after breast examination and may cause nipple discharge or bleeding. Intraductal papilloma most commonly oc…- ヒトパピローマウイルス（HPV）検査の世界市場（～2026年） HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. The increasing incidence rate of cervical and vaginal cancer is the key driver for the market growth. Market Analysis and Insights: Global Human papilloma virus Testing M…
- 胆管癌治療の世界市場（～2026年） Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcin…
- カルシフィラキシス治療の世界市場（～2026年） Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a rare condition characterized by calcification or the aggregation of calcium in a patient’s blood vessels and the development of thrombosis. This can lead to the death of cells in a patient’s skin and fatty tissues, thereby causi…
- 更年期障害の世界市場（～2026年） Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children. Menopause typically occurs between 49 and 52 years of age. Medical professionals often define menopause as having occurred when a woman h…